💙 🔷 Not impressed by Big Tech in Q3? Explore these Blue Chip Bargains insteadUnlock them all

BRIEF-U.S. joins lawsuit accusing Valeant's Salix unit of paying kickbacks to doctors

Published 2016-06-09, 03:47 p/m
© Reuters.  BRIEF-U.S. joins lawsuit accusing Valeant's Salix unit of paying kickbacks to doctors
BHC
-

June 9 (Reuters) - Valeant Pharmaceuticals International Inc (NYSE:VRX) VRX.TO :
* U.S. says it partially intervenes in whistleblower lawsuit against valeant's
VRX.TO salix pharmaceuticals unit -- court filing
* U.S. joins lawsuit as to claims that salix paid doctors to induce them to
prescribe several of its drugs, medical devices
* U.S. says the payments violated federal anti-kickback laws
* U.S. says salix also violated false claims act by submitting false claims for
the products to medicaid, medicare
* U.S. says the alleged wrongdoing occurred between 2009-2013, prior to
valeant's purchase of salix
* U.S. says it is not intervening with regard to claims that salix improperly
marketed some of the products for off-label uses

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.